For patients who have undergone successful catheter ablation for atrial fibrillation, treatment with rivaroxaban does not offer superior stroke protection versus aspirin.
No significant difference seen in composite outcome of stroke, systemic embolism, new covert embolic stroke.
While the anticoagulant apixaban significantly increased the risk of major bleeding compared to aspirin in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback